Catalyst Biosciences (CBIO) Reports Q2 Loss of $0.42/Share

Catalyst Biosciences (NASDAQ: CBIO) reported Q2 EPS of ($0.42), versus ($4.60) reported last year.

For earnings history and earnings-related data on Catalyst Biosciences (CBIO) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• ICICI Securities Starts Cemindia Projects (CEMPRO:IN) at Buy (1)
• Celcuity (CELC) Reiterates at Market Outperform by Citizens Ahead of Upcoming Launch